It is known that genetic factors, which affect metabolic pathways involved in adipogenesis, fat distribution, insulin signaling, and insulin resistance, can modulate the predisposition of developing obesity-related complications and lead to MUO [28]. The gene discussed is INS; the disease is Obesity.